Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updates the page from Revision: v3.0.1 to Revision: v3.0.2, signaling a new release. The 'Back to Top' link/element has been removed, a minor navigation-quality change.
    Difference
    0.1%
    Check dated 2025-09-14T21:36:38.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T17:40:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location details, as well as specific medical conditions related to non-Hodgkin lymphoma. Several previous location references and related medical topics have been removed.
    Difference
    12%
    Check dated 2025-08-31T12:13:17.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.3%
    Check dated 2025-08-24T08:06:05.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:38:47.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:34:05.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.